Abstract
Substance use/abuse remains a major problem in the world. The use of both legal (alcohol, tobacco, caffeine) and illegal drugs (androgenic anabolic steroids, amphetamines, benzodiazepines, cannabis, cocaine, heroin/opiates, hallucinogens, inhalants, khat, and prescribed/misused drugs) is associated with serious morbidity (health consequences) and mortality. Several chapters in this section discuss epidemiology, pharmacology, and various therapeutic interventions available for clinical management of health consequences of various substance use disorders. It should be noted that even though the treatment of substance use disorders with a wide range of clinical symptoms is complex, effective clinical management is achievable with integrated programs of health care. It is anticipated that the reader at the global level will benefit from the current knowledge on clinical management of health effects of drugs of abuse presented in this section.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Center for Behavioral Health Statistics and Quality. 2017 national survey on drug use and health: detailed tables. Substance abuse and mental health services administration, Rockville, MD; 2018. https://www.samhsa.gov/.../NSDUHDetailedTabs2017/NSDUHDetailedTabs2017.pdf; https://www.samhsa.gov/sites/default/files/nsduh-ppt-09-2018.pptx. Accessed 14 July 2019.
Centers for Disease Control and Prevention. Quitting smoking among adults—United States, 2000–2015. Morb Mortal Wkly Rep. 2017;65(52):1457–64. https://www.cdc.gov/mmwr/volumes/65/wr/mm6552a1.htm. Accessed 14 July 2019.
World Drug Report. United Nations publication, Sales No. E.18.XI.9; 2018. https://www.unodc.org/wdr2018. Accessed 14 July 2019.
Acknowledgments
The author is grateful to the National Institute on Drug Abuse, NIH, for an opportunity to continue to serve as a special volunteer to be able to collaborate with NIH and other national and international colleagues. The author is also grateful to his NIDA colleague, Dr. Kris Bough, program director, Division of Basic Neuroscience and Behavior Research, for valuable suggestions in the preparation of this chapter and the section as the co-editor.
Disclosures
The opinions in this chapter are of the author and do not reflect those of the National Institute on Drug Abuse, National Institutes of Health, USA.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Khalsa, J.H. (2021). Drugs of Abuse and Pharmacotherapies for Substance Use Disorders: Introduction. In: el-Guebaly, N., Carrà , G., Galanter, M., Baldacchino, A.M. (eds) Textbook of Addiction Treatment. Springer, Cham. https://doi.org/10.1007/978-3-030-36391-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-36391-8_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-36390-1
Online ISBN: 978-3-030-36391-8
eBook Packages: MedicineMedicine (R0)